Back to search

National and Kapodistrian University of Athens

Μεταβολικό σύνδρομο και υδρόθειο: παθοφυσιολογικοί μηχανισμοί και φαρμακολογικές προσεγγίσεις

Abstract

dc:description

Metabolic syndrome (MetS) is a complex pathophysiological condition characterized by the co-existence of obesity, insulin resistance, hypertension, and dyslipidemia. These metabolic abnormalities increase the risk and severity of cardiovascular disease and diabetes mellitus. Hydrogen sulfide (H2S) is an endogenously produced signaling molecule, involved in several pathways. It plays a crucial role in cardiovascular homeostasis and its deficiency due to an imbalance between H2S synthesis or / and degradation is commonly observed in obesity and cardiovascular disease. Herein, we determine the role of H2S as a possible link between MetS and the cardiovascular system pathophysiology in a mouse model of the disease. We focused on 3-mercaptopyruvate sulfurtransferase (MPST), a cysteine-catabolizing enzyme that yields pyruvate and H2S and plays a central role in the regulation of energy homeostasis. For this purpose, C57BL6/J male mice were fed a high fat diet (HFD; 45% of calories from fat) for 15 weeks to induce obesity and hyperglycemia, and also received a nitric oxide synthase inhibitor, (L-NAME, 0.5g/L in drinking water), during the last 5 weeks to induce hypertension. The combination of HFD and drug-induced hypertension leads to MetS that subsequently caused a mild left ventricular (LV) diastolic dysfunction, cardiac fibrosis and vascular endothelial dysfunction. Free H2S and sulfane sulfur levels were reduced in the aorta of mice with MetS, but not the heart. Also, from the enzymes tested in MetS, MPST and thiosulfate sulfurtransferase (TST) were reduced in the aorta, while a similar effect was observed in the subcutaneous white adipose tissue of mice with MetS. Furthermore, global MPST deletion worsens the MetS phenotype induced by HFD+LNAME, resulting in increased body weight and greater glucose intolerance, but similar degree of blood pressure elevation compared to WT mice. Mpst-/- in MetS were also characterized by deterioration of cardiac health as evidenced by increased cardiac fibrosis and reduced exercise performance, but without any aggravation in the echocardiography parameters tested. Most importantly MPST ablation caused an upregulation of genes involved in immune responses in the aorta. Comparison of the total transcriptome, as investigated after RNA sequencing, suggested infiltration of the vascular wall with leukocytes and activation of pro-inflammatory T-cells in the vessels of Mpst-/- mice with MetS. Finally, pharmacological restoration of H2S levels using two different experimental drugs ameliorates the MetS comorbidities. The administration of SG1002 ameliorates obesity and glucose metabolism, while GYY4137 shows additional antihypertensive effects. GYY4137 managed to reverse all the MetS comorbidities and protect against some of its cardiovascular consequences. GYY4137 administration in MetS reduces cardiac fibrosis, improves the endothelium-dependent relaxation and affects the expression of some inflammation markers in the aorta of Mpst-/- with MetS. The above data provide evidence that MetS causes changes in some enzymes responsible for H2S production and degradation in the aorta, resulting in reduction of H2S endogenous levels. Inactivation of the Mpst gene affects MetS parameters and results in vascular inflammation and deterioration of cardiac function. H2S supplementation emerges as a potential therapeutic approach to treat the metabolic and cardiovascular abnormalities associated with MetS.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Zampas, Paraskevas
  • Ζάμπας, Παρασκευάς

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58832

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Zampas, Paraskevas; Ζάμπας, Παρασκευάς. Μεταβολικό σύνδρομο και υδρόθειο: παθοφυσιολογικοί μηχανισμοί και φαρμακολογικές προσεγγίσεις. National and Kapodistrian University of Athens, 2025. http://hdl.handle.net/10442/hedi/58832